EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review

Samantha Ligertwood, Femi E Ayeni iD, Andrew Parsonson, Senarath Edirimanne

Cancer Chemotherapy and Pharmacology · 12.08.2026 · 96 (1)

DOI: 10.1007/s00280-026-04940-7 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 12.08.2026. Verfasst von Samantha Ligertwood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Body Composition, Neoadjuvant Therapy, Breast Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the leading cause of cancer-related death in women worldwide. There is increasing interest in using detailed body composition parameters, such as skeletal muscle mass and adiposity, to better predict treatment response, toxicity, and survival in breast cancer patients receiving neoadjuvant chemotherapy (NAC). This study synthesised current literature on the effect of body composition in breast cancer patients undergoing NAC and identified gaps for future research.

Methods

A scoping review was conducted in accordance with PRISMA-ScR and Arksey & O’Malley frameworks. Embase, MEDLINE, PubMed, and Google Scholar were searched for studies published between 2010 and 2025 to map available evidence. Eligible studies included female breast cancer patients receiving NAC with body composition assessment and at least one outcome of response, toxicity, or prognosis.

Results

Twenty studies met inclusion criteria. Computed tomography at the L3 vertebral level was the most common assessment method. Findings were heterogeneous; 3 studies reported a statistically significant association between sarcopenia and reduced pathological response, while results for adiposity were inconsistent. Half of the studies assessing toxicity reported higher toxicity rates in patients with sarcopenia and/or adiposity. Prognostic findings were variable, with some studies reporting associations with visceral adiposity, and only one study reporting a significant association with sarcopenia.

Conclusions

Evidence regarding the relationship between adiposity and NAC toxicity and prognosis in breast cancer remains suggestive, while findings for sarcopenia are inconsistent. Prospective, standardised studies are needed to clarify the role of body composition in breast cancer outcomes and its relevance in treatment planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body CompositionNeoadjuvant TherapyBreast NeoplasmsHumansFemalePrognosisSarcopeniaAdiposity

Stichwörter der Autor:innen

Adipose tissueAdiposityBody compositionBreast cancerPathological responsePrognosisSarcopeniaSkeletal muscleSubcutaneous fatSurvivalVisceral fat

Autor:innen und Institutionen

  • Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Sydney Medical School, The University of Sydney, Sydney, Australia. femi.ayeni@sydney.edu.au.
  • Nepean Institute of Academic Surgery, The University of Sydney, 62 Derby St, Penrith, NSW, 2750, Australia. femi.ayeni@sydney.edu.au.
  • Department of Medical Oncology, Nepean Hospital, Penrith, NSW, Australia.
  • Nepean Institute of Academic Surgery, The University of Sydney, 62 Derby St, Penrith, NSW, 2750, Australia.

ORCID-Profile: Femi E Ayeni

Förderung

  • The University of Sydney

Zitieren

APA

Ligertwood, S., Ayeni, F. E., Parsonson, A., & Edirimanne, S. (2026). Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04940-7

Vancouver

Ligertwood S, Ayeni FE, Parsonson A, Edirimanne S. Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04940-7

BibTeX
@article{Ligertwood2026,
  author = {Ligertwood, Samantha and Ayeni, Femi E and Parsonson, Andrew and Edirimanne, Senarath},
  title = {Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  volume = {96},
  number = {1},
  doi = {10.1007/s00280-026-04940-7}
}
Kostenlos starten →